drugset / Trial / NCT07231185

Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction

NCT07231185

Phase 2 Not yet recruiting 200 enrolled Aspargo Labs, Inc
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn how different sildenafil-based erectile dysfunction (ED) treatments affect erectile function in adult men. The main questions it aims to answer are: Does each assigned product improve erectile function over 12 weeks? What safety or tolerability issues occur when these products are used on an on-demand basis? Researchers will compare Hezkue® and Hezkue Turbo® with several commercially available sildenafil or sildenafil-plus-tadalafil products to see whether there are differences in effectiveness, treatment experience, or safety. Participants will: * Use one assigned ED treatment on demand for 12 weeks * Complete electronic diaries and questionnaires about sexual-encounter outcomes and treatment satisfaction * Attend study visits for safety checks, laboratory tests, and assessments of erectile function

Timeline

Start
2026-01
Primary completion
2026-03
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aristo Sildaristo Unknown Oral
Comparator BlueChew Unknown Oral
Comparator Galotam Unknown Oral
Subject Hezkue Unknown Oral
Subject Hezkue Turbo Unknown Oral
Comparator Lemonaid Health Sildenafil Unknown Oral
Comparator Sildenafil Unknown Oral
Comparator Tadalafil Small molecule Oral

Indications